In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...
A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
Chowhound on MSN
Why Chocolate Is So Expensive (And How Researchers Might Put A Stop To Rising Prices)
Chocolate prices have been rising due to complications in the supply chain, but Penn State researchers have made a ...
Researchers at Memorial Sloan Kettering Cancer Center (MSK) have developed some of the first robust laboratory models of a ...
Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...
Azalea Therapeutics, Inc., a biotechnology company redefining precision genomic medicines in vivo, today announced its official launch and completion of $82 million in seed and Series A financing to ...
CREATE Medicines, Inc. (formerly Myeloid Therapeutics) today announced new preclinical data for RetroT, the company's fully RNA-encoded, site-specific gene-integration system, presented at the Cold ...
Rare tumors are defined as cancers with an incidence of less than 6 per 100,000 persons per year. Due to their low prevalence ...
Cas9 gene editing and artificial intelligence to create compact tomato plants optimized for vertical farming in ...
Intellia Therapeutics, Inc. is rated Hold due to uncertainty from dosing pause in its MAGNITUDE program for ATTR. Learn more ...
VEXAS syndrome is an a confounding adult-onset inflammatory disease first described in 2020, which affects 1 in 4,000 men ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback